Avinger (NASDAQ:AVGR – Get Free Report) is expected to announce its earnings results before the market opens on Wednesday, March 19th. Analysts expect the company to announce earnings of ($0.40) per share and revenue of $1.86 million for the quarter.
Avinger Stock Performance
Shares of NASDAQ AVGR opened at $0.47 on Tuesday. Avinger has a 52 week low of $0.36 and a 52 week high of $4.37. The stock has a market cap of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09. The company’s 50-day moving average price is $0.53 and its 200 day moving average price is $0.77.
Analyst Ratings Changes
Separately, StockNews.com initiated coverage on shares of Avinger in a research note on Monday, March 10th. They set a “hold” rating on the stock.
About Avinger
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Read More
- Five stocks we like better than Avinger
- How to buy stock: A step-by-step guide for beginners
- Can TikTok Stock Picks Really Make You Rich?
- What is a Bond Market Holiday? How to Invest and Trade
- The “Quality” Rotation: Back to Basics Investing
- Do ETFs Pay Dividends? What You Need to Know
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.
